Adaptive Biotechnologies Corporation (ADPT)

Adaptive Biotechnologies Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	43.16	47.92	65.06	90.03	139.07	123.44
Short-Term Investments	154.71	174.37	281.34	408.17	214	564.83
Cash & Short-Term Investments	197.87	222.29	346.4	498.2	353.06	688.27
Cash Growth	-32.21%	-35.83%	-30.47%	41.11%	-48.70%	19.31%
Accounts Receivable	44.29	41.73	37.97	40.06	17.41	10.05
Other Receivables	1.3	1.3	1	0.8	1.4	2.5
Receivables	45.59	43.03	38.97	40.86	18.81	12.55
Inventory	8.4	8.44	14.45	14.45	19.26	14.06
Prepaid Expenses	10	9.99	10.37	8.64	11.62	12.04
Total Current Assets	261.86	283.75	410.19	562.15	402.75	726.91
Property, Plant & Equipment	84.39	94.38	120.32	164.21	172.94	139.04
Long-Term Investments	24.1	33.66	-	-	217.15	118.53
Goodwill	118.97	118.97	118.97	118.97	118.97	118.97
Other Intangible Assets	2.58	3.43	5.13	6.83	8.53	10.23
Other Long-Term Assets	4.73	5.18	6.52	4.46	3.01	2.74
Total Assets	496.64	539.38	661.13	856.62	923.34	1,116
Accounts Payable	6.91	7.27	7.72	8.08	3.31	3.24
Accrued Expenses	16.91	20.67	20.39	24.1	22.2	18.92
Current Portion of Long-Term Debt	3.07	0.87	-	-	-	-
Current Portion of Leases	9.96	10.24	9.38	9.23	5.06	3.53
Current Income Taxes Payable	-	0.18	0.06	0.19	0.39	0.37
Current Unearned Revenue	55.3	55.69	48.63	64.12	80.46	73.32
Other Current Liabilities	-	3.15	1.84	4.07	2.39	5.82
Total Current Liabilities	92.14	98.05	88.02	109.79	113.81	105.2
Long-Term Debt	130.5	132.41	130.66	125.36	-	-
Long-Term Leases	74.41	79.15	89.39	98.77	106.69	104.33
Long-Term Unearned Revenue	20.03	27.26	44.79	58.6	98.75	163.62
Other Long-Term Liabilities	0.02	0.02	-	-	-	-
Total Liabilities	317.1	336.89	352.86	392.52	319.24	373.15
Common Stock	0.02	0.01	0.01	0.01	0.01	0.01
Additional Paid-In Capital	1,539	1,506	1,453	1,387	1,324	1,254
Retained Earnings	-1,359	-1,304	-1,144	-919.08	-718.89	-511.61
Comprehensive Income & Other	0.07	0.17	0.22	-4.12	-1.14	0.89
Total Common Equity	179.72	202.71	308.4	464.17	603.99	743.27
Minority Interest	-0.18	-0.22	-0.12	-0.07	0.11	-
Shareholders' Equity	179.54	202.49	308.28	464.1	604.1	743.27
Total Liabilities & Equity	496.64	539.38	661.13	856.62	923.34	1,116
Total Debt	217.94	222.67	229.43	233.36	111.74	107.86
Net Cash (Debt)	4.04	33.29	116.97	264.83	458.47	698.93
Net Cash Growth	-93.85%	-71.54%	-55.83%	-42.23%	-34.41%	8.24%
Net Cash Per Share	0.03	0.23	0.81	1.86	3.27	5.33
Filing Date Shares Outstanding	152.27	148.58	145.09	143.23	141.58	139.22
Total Common Shares Outstanding	152.23	147.77	145.08	143.11	141.39	137.65
Working Capital	169.72	185.7	322.17	452.36	288.94	621.72
Book Value Per Share	1.18	1.37	2.13	3.24	4.27	5.40
Tangible Book Value	58.16	80.31	184.3	338.37	476.49	614.07
Tangible Book Value Per Share	0.38	0.54	1.27	2.36	3.37	4.46
Machinery	-	59.33	61.36	56.7	48.88	34.08
Construction In Progress	-	2.57	3.41	7.63	5.66	7.19
Leasehold Improvements	-	73.28	74.73	72.4	65.96	21.95

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q